Gelteq - GELS Net earnings per one share for the last twelve months

Gelteq Ltd (GELS) - corporate logo

Gelteq Limited generates revenue by licensing gel drug delivery systems, collecting royalties from pharmaceutical behemoths. The YoY TTM growth in net income per share visualizes this efficiency, with the value stabilizing at 0.00. The monetization of intellectual property relies on patents for non-pill drug administration. High certification barriers and unique ingredient protection technologies create a robust market moat.

GELS: Gelteq Net earnings per share for the last 12 months 11/23/2025 - 11/17/2026

Gelteq - analytical breakdowns and key metrics (GELS)

- stock quotes and analyst forecast:
Fundamental company valuation:GELS - Gelteq Limited Inc
Brand item of gelteq.com

Investors assess asset quality through the dynamics of annual earnings per share, utilizing the EPS TTM annual growth rate to promptly identify changes in profitability without quarterly delays. A decline in this metric signals rising operating expenses, which for Gelteq Limited (GELS) logically reflects clinical trial costs in the absence of current commercial sales.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Applied Therapeutics APLT|RNTX - Earnings per share for the last twelve months|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)